echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hetero and Beimei Pharmaceuticals launch antiviral drugs in China

    Hetero and Beimei Pharmaceuticals launch antiviral drugs in China

    • Last Update: 2022-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Beijing, November 12, 2021/PRNewswire/ - Hetero, a world-renowned vertically integrated pharmaceutical organization, and Shenzhen Beimei Pharmaceuticals jointly announced that they have obtained oseltamivir phosphate from the Chinese drug regulatory agency, the National Medical Products Administration.


    Oseltamivir phosphate is an antiviral drug used to treat acute uncomplicated influenza infections in adults, adolescents, and children (2 weeks of age and older)


    According to WHO estimates, seasonal influenza alone may cause 290,000 to 650,000 deaths each year due to respiratory diseases


    Dr.


    Ms.


    About Hetero 

    Hetero is a world-renowned vertically integrated pharmaceutical organization engaged in the research and development, manufacturing and marketing of high-quality chemical and biological drugs in different therapeutic fields


    About Shenzhen Beimei Pharmaceutical Co.


    Shenzhen Beimei Pharmaceutical Co.


    Source: Hetero and Shenzhen Beimei Pharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.